Presented by Team Paris Bettencourt 2020
Amandine Maire1, Anu Susan Kurian1, Chetan Kumar Velumurugan1, Nicolas Levrier1, Nikola Zarevski1, Valerie March1, Xavier Olessa-Daragon1,
1Student Team Member, 2Team Mentor
Abstract
Line 129: | Line 129: | ||
<p>In the context of COVID-19 pandemic, we were, as most of the other iGEM teams confined at home.</p> | <p>In the context of COVID-19 pandemic, we were, as most of the other iGEM teams confined at home.</p> | ||
<div class="subsection third"> | <div class="subsection third"> | ||
− | + | <img src="https://static.igem.org/mediawiki/2020/f/f3/T--Example--Poster_Inspiration.png"> | |
</div> | </div> | ||
<div class="subsection two_thirds"> | <div class="subsection two_thirds"> |
Presented by Team Paris Bettencourt 2020
Amandine Maire1, Anu Susan Kurian1, Chetan Kumar Velumurugan1, Nicolas Levrier1, Nikola Zarevski1, Valerie March1, Xavier Olessa-Daragon1,
1Student Team Member, 2Team Mentor
1. Sample and Sequence the Human Skin Microbiome
Our first objective, pursued as part of the Quaranskin project, is to study the impact of environmental and behavioral factors on the skin microbiome and to provide a new database to study its composition in the context of reduced social and environmental interactions.
2. Design tools to engineer the bacterium S. epidermidis
Our second objective is to make S. epidermidis an efficient synthetic biology chassis that can be used to monitor the population dynamics of the skin microbiome. This in order to maintain its equilibrium and to avoid pathologies induced by dysbiosis.
In the context of COVID-19 pandemic, we were, as most of the other iGEM teams confined at home.
As this situation was unprecedented, we were wondering if the lockdown could have an impact on human health and more specifically on the composition of our skin microbiome.